Literature DB >> 16763207

Ontogeny, function, and peripheral homeostasis of regulatory T cells in the absence of interleukin-7.

Régis Peffault de Latour1, Hélène C Dujardin, Florence Mishellany, Odile Burlen-Defranoux, Julien Zuber, Rute Marques, James Di Santo, Ana Cumano, Paulo Vieira, Antonio Bandeira.   

Abstract

Mice lacking interleukin-7 (IL-7-/- mice) have no signs of autoimmune disease, contrary to other models of lymphopenia. We investigated whether the absence of disease was due to the fact that IL-7 is dispensable for the ontogeny, function, and homeostasis of regulatory CD4+ T cells. We show here that the establishment of the peripheral pool of Foxp3-expressing regulatory cells is IL-7 independent, and the premature involution of the thymus in IL-7-/- mice does not change the representation of the CD4+CD25+ T-cell compartment. In addition, CD4+CD25+ T cells expand in the absence of IL-7, without losing Foxp3 expression. The frequency of activated peripheral CD4+ T cells increases with age in both the CD25- and CD25+ compartments, with the CD4+CD25+ T cells displaying signs of constant activation. IL-7-/- CD4+CD25+ T cells control inflammatory bowel disease induced by IL-7-/- T cells even in hosts lacking IL-7. Depletion of the CD25+ T-cell subset after thymic involution results in a mild form of inflammatory bowel disease (IBD), which resolves concomitantly with the regeneration of this subset. This study shows for the first time that IL-7-/- mice have a robust regulatory Foxp3-expressing CD4+ T-cell compartment that controls T-cell-mediated disease. It also highlights the potential of the regulatory Foxp3-expressing CD4+CD25- T-cell population to restore a functional CD4+CD25+ T-cell compartment through an IL-7-independent pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763207     DOI: 10.1182/blood-2006-04-017947

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

Review 1.  Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity.

Authors:  Ronit Mazor; Emily M King; Masanori Onda; Nicolas Cuburu; Selamawit Addissie; Devorah Crown; Xiu-Fen Liu; Takashi Kei Kishimoto; Ira Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

2.  An in vivo IL-7 requirement for peripheral Foxp3+ regulatory T cell homeostasis.

Authors:  Grace Y Kim; Davinna L Ligons; Changwan Hong; Megan A Luckey; Hilary R Keller; Xuguang Tai; Philip J Lucas; Ronald E Gress; Jung-Hyun Park
Journal:  J Immunol       Date:  2012-05-16       Impact factor: 5.422

Review 3.  Chemotherapy and immunotherapy: A close interplay to fight cancer?

Authors:  Aurélie Hanoteau; Muriel Moser
Journal:  Oncoimmunology       Date:  2016-06-21       Impact factor: 8.110

Review 4.  Cytokine Signaling in the Development and Homeostasis of Regulatory T cells.

Authors:  Kevin H Toomer; Thomas R Malek
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-03-01       Impact factor: 10.005

Review 5.  IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis.

Authors:  Florent Carrette; Charles D Surh
Journal:  Semin Immunol       Date:  2012-05-01       Impact factor: 11.130

6.  Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP.

Authors:  Renata Mazzucchelli; Julie A Hixon; Rosanne Spolski; Xin Chen; Wen Qing Li; Veronica L Hall; Jami Willette-Brown; Arthur A Hurwitz; Warren J Leonard; Scott K Durum
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

7.  A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells.

Authors:  Allison L Bayer; Joon Youb Lee; Anabel de la Barrera; Charles D Surh; Thomas R Malek
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

8.  Impact of the TCR signal on regulatory T cell homeostasis, function, and trafficking.

Authors:  Joong Kyu Kim; Mark Klinger; Jonathan Benjamin; Yuanyuan Xiao; David J Erle; Dan R Littman; Nigel Killeen
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

9.  Host-derived interleukin-18 differentially impacts regulatory and conventional T cell expansion during acute graft-versus-host disease.

Authors:  Robert Zeiser; Elizabeth A Zambricki; Dennis Leveson-Gower; Neeraja Kambham; Andreas Beilhack; Robert S Negrin
Journal:  Biol Blood Marrow Transplant       Date:  2007-10-29       Impact factor: 5.742

10.  IL-2 family of cytokines in T regulatory cell development and homeostasis.

Authors:  Thomas R Malek; Aixin Yu; Linjian Zhu; Takaji Matsutani; Dennis Adeegbe; Allison L Bayer
Journal:  J Clin Immunol       Date:  2008-08-26       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.